Equasens's ROE % for the quarter that ended in Dec. 2025 was 17.46%. Equasens's PB Ratio for the quarter that ended in Dec. 2025 was 3.14.
Equasens's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was 5.56%.
Equasens ROE % Adjusted to Book Value Related Terms
Equasens ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Equasens's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PHF vs VEEV, BTSG, TEM: ROE % Adjusted to Book Value Comparison
For the Health Information Services subindustry, Equasens's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Equasens ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Equasens's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Equasens's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 5.56% mean?
Equasens (FRA:PHF) has a ROE % Adjusted to Book Value of 5.56% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Equasens and its competitors.
Is Equasens' ROE % Adjusted to Book Value too high?
Equasens' current ROE % Adjusted to Book Value is 5.56%. Overall, Equasens has a GF Score™ of 94/100, reflecting its overall financial health beyond just this single metric.
How does Equasens' ROE % Adjusted to Book Value compare to VEEV and BTSG?
Equasens' ROE % Adjusted to Book Value of 5.56% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Equasens and its competitors. Equasens's current ROE % Adjusted to Book Value is 5.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Equasens stock overvalued right now?
Equasens (FRA:PHF) has a current ROE % Adjusted to Book Value of 5.56%. The stock's GF Value™ is €85.23, compared to a current price of €52.77 — trading 38.1% below its estimated fair value. The current ROE % Adjusted to Book Value is 5.56%. Equasens' overall GF Score™ is 94/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Equasens (FRA:PHF), the current ROE % Adjusted to Book Value is 5.56% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Equasens (FRA:PHF) Overvalued in 2026?
Based on GuruFocus' analysis, Equasens stock appears to be undervalued.
The current stock price of €52.77 is trading 38.1% below its estimated GF Value™ of €85.23.
Key valuation signals for FRA:PHF:
ROE % Adjusted to Book Value: 5.56%
GF Value™: €85.23 vs. price of €52.77 (38.1% below fair value)
No single metric tells the full story. See the FRA:PHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centers) and patients in both primary and secondary care sectors. The various activities that the company is involved in include: pharmacy software publishing and integration, publishing of IT solutions for health and medical/social establishments, and development of solutions and infrastructures for e-Health. With operations in France (its key revenue-generating market), Italy, Belgium, Germany, Ireland, and the United Kingdom, it is developing the healthcare platform and an ecosystem in France and Europe, benefiting people by making its technology services available.
94GF Score
Get the complete analysis for FRA:PHF
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PHF has been successfully added to your 
